002370.SZ · 亚太药业
China A-shares · RS rating 23 · As of 2026-10-14
| Price | 5.04 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 45 / 44 / 49 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 20 / 8 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +64.4% |
| Distance from 52-week high | +44.4% |
| Market cap (USD) | $581.0M |